Published
- Primary-care clinicians
- Clinical pharmacy collaborators
- Transition-of-care teams
- Institutional healthcare teams
Prepared · sources accessed (UTC) · physician review still to be recorded
A medication list can look complete while a patient follows a different regimen. An order may be active although the pharmacy never dispensed it. A discontinued medicine may remain in a bottle, an automatic refill queue, or a caregiver’s organizer. A transition is complete only when the clinical team has addressed the intended regimen, unresolved discrepancies, practical access, and necessary monitoring.
This guide provides a workflow for outpatient teams reviewing care after hospitalization, specialist treatment, pharmacy changes, or another transition. It teaches how to organize the inquiry. It does not select drugs, doses, substitutions, or monitoring intervals for an individual patient.
Separate prescribed, dispensed, administered, and taken
Label each source according to what it can establish. A prescription records an instruction. A pharmacy record may establish dispensing. A medication administration record documents administration within its setting. The patient’s account helps establish actual use outside that setting. None automatically answers every other question.
Ask about prescription and nonprescription products, supplements, and preparations that may not appear in the main medication list. AHRQ’s MATCH introduction describes reconciliation as comparing regimens and resolving discrepancies with the prescriber. The point is a reasoned clinical reconciliation, not merely importing another electronic list.
Where sources disagree, preserve the disagreement long enough to investigate it. Ask when the information was obtained and whether a change occurred afterward. A “most recent” list can still contain older copied information.
Resolve a discontinued medicine that still appears active
Identify the stopping decision, the person responsible, its reason if documented, and whether it was intended to be permanent or temporary. Determine whether the patient understood the change and whether other systems still represent the earlier regimen. Do not instruct a patient to stop or restart a medication solely because two lists differ; obtain the appropriate clinical decision.
Once resolved, reconcile the relevant destinations: current clinical list, patient instructions, pharmacy communications, caregiver plan, and monitoring tasks. An old prescription may require a separate communication to the pharmacy. Confirm the process available in the actual system rather than assuming that changing an office list cancels every existing prescription elsewhere.
Retain an accurate history. A corrected current regimen should not erase the evidence of when and why the earlier regimen changed.
Explain a change in terms the patient can use
For each clinically approved change, make clear what continues, what stops, what starts, and what changes. Explain the purpose and relevant precautions in an individualized way. Ask the patient to describe how the plan fits their actual bottles, packaging, and daily routine.
If a caregiver manages medicines, establish their role and obtain information through the appropriate permission process. Separate the patient’s account from the caregiver’s account when they differ. Ask which person will obtain refills, organize doses, and communicate problems. Do not infer that a family member’s presence proves that support is available every day.
MATCH’s process-design chapter emphasizes defined responsibilities, a shared reconciled list, and patient participation. An organization can apply those principles while keeping a clear distinction between collecting information and making prescribing decisions.
Distinguish formulary decisions from access failures
A medication may be clinically selected but unavailable because of stock, coverage, authorization, cost, transportation, or an administrative mismatch. Record the particular obstacle. “Not taking” is insufficient if it hides that the patient never received the medicine.
Assign the access question to someone who can resolve or escalate it. A formulary substitution needs an authorized clinical decision; an alternative is not interchangeable merely because it belongs to a similar category. If access remains unresolved, return the problem to the clinician for a plan appropriate to the medication and patient rather than leaving it in an indefinite authorization queue.
Check what the patient is doing in the meantime. They may be continuing an old supply, borrowing a relative’s medicine, stretching doses, or taking nothing. Those possibilities require clarification and clinical assessment, not assumptions or blame.
Fictional worked case: three lists, two bottles, one unresolved plan
Fictional case. Ms. Patel returns to primary care after hospitalization. The discharge list reduces one medicine and stops a second. The office list retains both previous instructions. Her pharmacy has the new prescription, but she has not collected it because she believed the old bottle was equivalent. Her daughter reports filling a weekly organizer from both bottles.
The clinician compares the discharge decision, available clinical information, pharmacy record, and patient account. The team does not select the regimen by majority vote among the three lists. The prescribing decision is clarified and documented. Ms. Patel and her daughter receive a single current plan with the specific changes identified through the practice’s usual medication counseling process.
A coordinator confirms that the intended supply is obtainable. The clinician assigns any necessary follow-up assessment or laboratory monitoring, including who will review it. The daughter explains the plan back in her own words and identifies the person she will contact if the new supply is unavailable.
The packet does not name medicines, doses, organ function, or the reason for hospitalization. It cannot establish which regimen is clinically correct. It demonstrates the information and responsibility problems that need resolution before a confident statement that reconciliation is complete.
Give monitoring its own owner
A prescription change and a monitoring plan are related but separate tasks. Specify what must be assessed, when the clinician intends reassessment, who arranges it, who interprets the information, and what happens if it is not obtained. The relevant timing depends on the medicine, patient, and clinical circumstances.
Clarify shared care with specialists. “Cardiology follows” does not identify which clinician handles a newly ordered test or a report arriving in primary care. Record accepted responsibility and a fallback when the expected recipient is unavailable. If the clinical plan changes, update monitoring tasks so obsolete orders do not obscure the current ones.
Medication-transition worksheet
Use this worksheet inside an approved clinical workflow. Collect source facts before filling in the final-plan column.
| Field | Entry |
|---|---|
| Medication or preparation; patient’s actual use | ______ |
| Prescribed instruction and date | ______ |
| Dispensing or administration evidence | ______ |
| Competing instruction and its source | ______ |
| Question requiring a prescribing decision | ______ |
| Clarified plan; clinician and rationale | ______ |
| Patient understanding and access obstacle | ______ |
| Pharmacy or caregiver communication needed | ______ |
| Monitoring task, owner, and reassessment point | ______ |
| Confirmation of resolution or remaining uncertainty | ______ |
Before closing the transition, ask: Can the patient obtain the intended regimen? Can they explain the changes? Are material discrepancies resolved or visibly assigned? Is monitoring owned? Does the current list agree with the communicated plan? A “no” answer identifies unfinished work rather than automatically proving poor care.
Close the pharmacy and patient communication loop
Record the purpose of communications with the pharmacy: verify supply, clarify a prescription, resolve a discontinuation, or identify an access obstacle. Document the response and any remaining question. A successful fax or electronic transmission establishes delivery only to the extent supported by the system; it does not necessarily establish that the patient received the medicine.
Follow up selectively according to the clinical concern. The goal is to verify the consequential next step, not to generate redundant contacts for every routine prescription. A small process review can examine whether reported discrepancies actually reached a clinician and whether the agreed change reached the patient.
Questions readers ask
Is the discharge list always the correct list?
It is an important source, but its meaning may require clarification and later decisions may supersede it. Compare it with the clinical context and actual use rather than adopting it mechanically.
Can a staff member mark a discrepancy resolved?
Staff can document completed tasks within their role. A discrepancy requiring prescribing judgment needs the appropriate clinician’s decision. Define what the resolution status means so administrative completion does not imply an unmade medical decision.
Does dispensing prove adherence?
No. It can establish that a supply was dispensed under the relevant record. Actual use requires additional information, and even a patient account may leave uncertainty about timing or amounts.
Related resources and sources
Existing foundations: medication-continuity review, primary-care review, and clinical consulting. Continue with clinical case learning, downtime and handover, and the patient heart, kidney, and diabetes care plan.
Source and scope note. Primary sources are AHRQ MATCH’s introduction and process-design chapter, linked above. The toolkit originated in acute care and describes adaptation to other settings. This original workflow is not a drug-specific protocol. Prepared November 5, 2026 Pacific.